Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these personalized treatments faster, cheaper, and available to far more patients.
WASHINGTON - The Food and Drug Administration Wednesday granted supplemental approval for a breakthrough CRISPR gene therapy medication, making it the first available to treat young children with ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...
The Scottish Medicines Consortium (SMC) has accepted exagamglogene autotemcel (Casgevy, Vertex Pharmaceuticals) for use within NHS Scotland to treat sickle cell disease (SCD) in patients aged 12 years ...
Doctors say new gene-based treatments could offer long-term relief — and possible cures — for people living with sickle cell disease. Sickle cell disease has long shortened lives in the United States, ...
The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ...
The first patient in Louisiana to receive genetically edited therapy for sickle cell disease went home this week after months in isolation at Manning Family Children's Hospital in New Orleans. Daniel ...
Gene therapy has given sickle cell disease what medicine has long promised but rarely delivered: the possibility of a cure. Yet the slow uptake of Casgevy and Lyfgenia shows that even dazzling science ...
Share on Pinterest A Louisiana man has become the first in the Gulf South to be functionally cured of sickle cell disease using gene therapy. Image Credit: Marti Sans/Stocksy Daniel Cressy of ...
Daniel Cressy's illness was a barrier to getting his pilot's license, until a novel treatment was approved in the United ...